z-logo
open-access-imgOpen Access
Akt2 Deficiency is Associated with Anxiety and Depressive Behavior in Mice
Author(s) -
Christina Leibrock,
Teresa F. Ackermann,
Michael Hierlmeier,
Florian Läng,
Stefan Borgwardt,
Undine E. Lang
Publication year - 2013
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000354478
Subject(s) - behavioural despair test , elevated plus maze , protein kinase b , open field , morris water navigation task , anxiety , neurotrophic factors , psychology , mood disorders , gsk 3 , pi3k/akt/mtor pathway , brain derived neurotrophic factor , knockout mouse , akt2 , neuroscience , antidepressant , medicine , endocrinology , psychiatry , signal transduction , akt1 , hippocampus , biology , biochemistry , receptor
The economic burden associated with major depressive disorder and anxiety disorders render both disorders the most common and debilitating psychiatric illnesses. To date, the exact cellular and molecular mechanisms underlying the pathophysiology, successful treatment and prevention of these highly associated disorders have not been identified. Akt2 is a key protein in the phosphatidylinositide-3 (PI3K) / glycogen synthase 3 kinase (GSK3) signaling pathway, which in turn is involved in brain-derived neurotrophic factor (BDNF) effects on fear memory, mood stabilisation and action of several antidepressant drugs. The present study thus explored the impact of Akt2 on behaviour of mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom